SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 32 filers reported holding SINOVAC BIOTECH LTD in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $8 | -99.9% | 18 | 0.0% | 0.00% | – |
| Q3 2022 | $8,000 | 0.0% | 18 | 0.0% | 0.00% | – |
| Q2 2022 | $8,000 | 0.0% | 18 | 0.0% | 0.00% | – |
| Q1 2022 | $8,000 | +14.3% | 18 | -98.2% | 0.00% | – |
| Q4 2018 | $7,000 | -12.5% | 1,000 | 0.0% | 0.00% | – |
| Q3 2018 | $8,000 | +14.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | -56.2% | 1,000 | -50.0% | 0.00% | -100.0% |
| Q1 2018 | $16,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $16,000 | +14.3% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $14,000 | 0.0% | 2,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $14,000 | +133.3% | 2,000 | +100.0% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2016 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2016 | $6,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q4 2015 | $6,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Verity Asset Management, Inc. | 35,884 | $188,000 | 0.17% |
| Orbimed Advisors | 2,667,500 | $14,004,000 | 0.10% |
| Freedom Investment Management, Inc. | 157,295 | $826,000 | 0.08% |
| Pine River Capital Management L.P. | 1,095,041 | $5,749,000 | 0.06% |
| FIRST MANHATTAN CO. LLC. | 603,666 | $3,169,000 | 0.02% |
| FIL Ltd | 1,091,500 | $5,730,000 | 0.02% |
| Renaissance Technologies | 1,263,200 | $6,632,000 | 0.02% |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 179,899 | $944,000 | 0.01% |
| WELLINGTON MANAGEMENT GROUP LLP | 4,068,406 | $21,359,000 | 0.01% |
| ProShare Advisors LLC | 44,592 | $234,000 | 0.00% |